Antiatherosclerotic properties of oral cicaprost in hypercholesterolemic rabbits

Agents Actions Suppl. 1992:37:282-8. doi: 10.1007/978-3-0348-7262-1_39.

Abstract

The effects of the orally active prostacyclin mimetic cicaprost on morphologic and functional alterations of rabbit aorta was investigated in experimental hypercholesterolemia. Oral cicaprost resulted in a significantly reduced aortic atheromatous plaque formation and partially prevented hypercholesterolemia-induced impairment of endothelium-dependent relaxations. It is concluded that long-term substitution with PGI2 may beneficially influence the progression of atherosclerosis.

MeSH terms

  • Administration, Oral
  • Animals
  • Aorta, Thoracic / pathology
  • Arteriosclerosis / pathology
  • Arteriosclerosis / physiopathology
  • Arteriosclerosis / prevention & control*
  • Blood Vessels / pathology
  • Blood Vessels / physiopathology
  • Epoprostenol / administration & dosage
  • Epoprostenol / analogs & derivatives*
  • Epoprostenol / therapeutic use
  • Hypercholesterolemia / complications*
  • Lipids / blood
  • Muscle Relaxation / physiology
  • Muscle, Smooth, Vascular / physiology
  • Rabbits

Substances

  • Lipids
  • Epoprostenol
  • cicaprost